Pharmaceutical Research and Manufacturers of America (PhRMA) expressed “serious concerns” with the federal government’s opposition to Johnson & Johnson’s (J&J’s) [...] …
Category: Regulatory
Federal regulators’ inaction on the 340B program’s interactions with Medicare drug price negotiations will likely lead drugmakers to pursue “manufacturer-friendly” [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A new federal regulation updating the definition of a covered outpatient drug could change the number of drugs covered under [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Arkansas Begins Enforcement Against AstraZeneca for Allegedly Violating Contract Pharmacy Access Law
Arkansas officials initiated enforcement proceedings earlier this week against AstraZeneca for allegedly violating a state law that prohibits drugmaker 340B [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Federal regulators issued final guidance for the next round of Medicare drug price negotiations yesterday but did not propose remedies [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Multiple 340B provider groups have applauded the federal government for threatening “strong” enforcement actions that led Johnson & Johnson (J&J) [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Drug industry vendor Kalderos last week launched a new drug discount platform with 340B rebate capabilities as its prior lawsuit [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Breaking News
J&J Abandons 340B Rebate Due to HRSA’s Enforcement Threats But Defends Model in Letter to Agency
Johnson & Johnson (J&J) notified the Health Resources and Services Administration (HRSA) this morning that it will drop its 340B [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Breaking News
188 Bipartisan House Members Urge HHS Action Against J&J’s ‘Unlawful’ 340B Rebate Proposal
A bipartisan group of 188 House lawmakers urged the federal government Friday to “use every enforcement tool” at its disposal [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Breaking News
HRSA to J&J: End 340B Rebate by Monday or Lose Access to Key Government Health Insurance Markets
The federal agency overseeing the 340B program has doubled down on its threat to terminate Johnson & Johnson’s (J&J’s) access [...] …